This study is accepting new patients by invitation only
Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101
a study on Multiple Myeloma
Multiple Myeloma CAR-T cells Rimiducid may be administered as indicated
Lead Scientist at UCSF
- Nina Shah
Dr. Nina Shah is a hematologist who specializes in the treatment of multiple myeloma, a type of cancer affecting the blood marrow. She treats patients at the Hematology and Blood Marrow and Transplant Clinic. Nina received a bachelor’s degree in cognitive neuroscience at Harvard University, followed by a medical degree from New York University School of Medicine.
- accepting new patients by invitation only
- Start Date
- Completion Date
- Poseida Therapeutics, Inc.
- Phase 1
- Study Type
- Last Updated